💼 Business 2d ago · Ekta Bagri

BDTX and Brain Metastases: Why CNS Activity Could Matter in 2026

Quartz (QZ)
Global business news for the new economy
View Channel →
Source ↗ 👁 2 💬 0
BDTX spotlights silevertinib's 86% CNS response in NSCLC, with 2026 durability data and a glioblastoma push shaping its brain-metastasis strategy.

Comments (0)

Sign in to join the discussion

More Like This

📰
Why is quantum computing seen as a challenge to Bitcoin?
All News · 4h ago
BitMEX Report Finds 500%+ Increase in Tokenised Commodities and Equity Perpetuals
All News · 4h ago
Japan targets Asian oil alliance as supply bottlenecks persist
All News · 4h ago
Money to burn? The humble matchbox gets a £235 makeover
Business | The Guardian · 5h ago
Low-tax Texas opens London office to lure jobs and investment
Business | The Guardian · 5h ago
Taemin Dazzles At Coachella Debut, Premieres 6 New Songs: Full Setlist
Forbes - Business · 5h ago